{"id":"W4225276302","doi":"10.5826/dpc.1202a104","title":"Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial","year":2022,"lang":"en","type":"article","venue":"Dermatology Practical & Conceptual","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriatic arthritis; Adalimumab; Psoriasis; Dermatology; Plaque psoriasis; Arthritis; Traditional medicine; Internal medicine; Secukinumab; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005314821,0.001347444,0.002868267,0.0002964705,0.0002699278,0.001234223,0.0007987045,0.001191346,0.004381471],"category_scores_gemma":[0.003510264,0.0005914388,0.003028812,0.0002952148,0.0009914346,0.000985734,0.0006222237,0.002188723,0.0006543545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006392164,"about_ca_system_score_gemma":0.0008160205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004936986,"about_ca_topic_score_gemma":0.0008411879,"domain_scores_codex":[0.9976121,0.001554106,0.0001610433,0.0003111117,0.0001918869,0.0001697202],"domain_scores_gemma":[0.9983162,0.000504313,0.000493241,0.000225203,0.00009322942,0.00036785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9805182,0.002411762,0.002039094,0.0005151785,0.002045379,0.00001886079,0.00005023413,0.0002629606,0.001323056,0.00006940764,0.0005881122,0.0101578],"study_design_scores_gemma":[0.9477081,0.04325192,0.006361373,0.00003763105,0.001261148,0.00004041052,0.00002165995,0.0004673844,0.0002691434,0.0001626435,0.000402518,0.00001608612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919705,0.004283012,0.0004385507,0.0003651584,0.0002629765,0.0008286029,0.0006283326,0.00006773842,0.001155098],"genre_scores_gemma":[0.993656,0.001218302,0.0007801332,0.0006839937,0.000416099,0.0009271453,0.001104941,0.00001796335,0.001195377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005314821,"threshold_uncertainty_score":0.02810782,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02590724216956507,"score_gpt":0.2801561688591698,"score_spread":0.2542489266896047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}